Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Project Grant

Ottawa Hospital Research Institute

$895,050.00

Screening for Occult Malignancy in Patients with Unprovoked Venous Thromboembolism: a Randomized Controlled Trial using 18F-Fluorodeoxyglucose Positron Emission Computed Tomography. SOME-2 Trial

FY 2018-19

Summary
Blood clots in leg veins (deep vein thrombosis) or lung arteries (pulmonary embolism) that happen for no reason are both called "unprovoked venous thromboembolism" . These unexplained blood clots can be the first manifestation of cancer. Current data suggest that after the occurrence of a first unexplained blood clot, approximately 5% of the patients will be diagnosed with cancer in the following year. In patients older than 50, this rate reaches 7%. Unfortunately, all types of cancers can be found and whether systematic cancer screening should be performed has remained controversial: extensive cancer testing may find more cancers but is potentially uncomfortable and harmful for patients. Markedly, two recent studies demonstrated that the number or cancer diagnosed or missed after an extensive screening approach was not different to the numbers observed after a limited screening approach (medical history, physical examination, basic blood work and chest X-ray). However, focusing workup in patients older than 50 could greatly improve the performance of extending cancer screening strategies. A PET scan, is a non-invasive whole body imaging test performed to find out many cancers at once. It combines computed tomography (CT) with functional imaging using sugar. It is routinely used for the diagnosis, staging and restaging of various cancers in oncology. Previous studies showed promising performances in finding an unknown cancer at the time of an unexplained blood clot by using PET scan. Our research question is whether a PET scan misses less cancers than a limited cancer screening plan in patients aged 50 years or more who are diagnosed with a first unexplained blood clot. We hope our study will also help in identifying more curable cancers when PET scan is performed and that a negative PET scan means that the patient has a risk of subsequent cancer similar to the general population.
Program
Project Grant
Location
Ontario, Canada
Recipient Type
Other
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
401385
Name
Delluc Aurelien
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Clinical
Prcname2
Randomized Controlled Trials
Projecttitle
Screening for Occult Malignancy in Patients with Unprovoked Venous Thromboembolism: a Randomized Controlled Trial using 18F-Fluorodeoxyglucose Positron Emission Computed Tomography. SOME-2 Trial
Programtype2
Operating Grants
Orgnameinp2
Ottawa Hospital Research Institute
Cihramount2
$895,050
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Cancer Screening; Pet/Ct; Randomized Control Trial; Unprovoked Venous Thromboembolism
Abstract
Blood clots in leg veins (deep vein thrombosis) or lung arteries (pulmonary embolism) that happen for no reason are both called "unprovoked venous thromboembolism" . These unexplained blood clots can be the first manifestation of cancer. Current data suggest that after the occurrence of a first unexplained blood clot, approximately 5% of the patients will be diagnosed with cancer in the following year. In patients older than 50, this rate reaches 7%. Unfortunately, all types of cancers can be found and whether systematic cancer screening should be performed has remained controversial: extensive cancer testing may find more cancers but is potentially uncomfortable and harmful for patients. Markedly, two recent studies demonstrated that the number or cancer diagnosed or missed after an extensive screening approach was not different to the numbers observed after a limited screening approach (medical history, physical examination, basic blood work and chest X-ray). However, focusing workup in patients older than 50 could greatly improve the performance of extending cancer screening strategies. A PET scan, is a non-invasive whole body imaging test performed to find out many cancers at once. It combines computed tomography (CT) with functional imaging using sugar. It is routinely used for the diagnosis, staging and restaging of various cancers in oncology. Previous studies showed promising performances in finding an unknown cancer at the time of an unexplained blood clot by using PET scan. Our research question is whether a PET scan misses less cancers than a limited cancer screening plan in patients aged 50 years or more who are diagnosed with a first unexplained blood clot. We hope our study will also help in identifying more curable cancers when PET scan is performed and that a negative PET scan means that the patient has a risk of subsequent cancer similar to the general population.
Competitiondate
201903
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Delluc, Aurelien; Carrier, Marc
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $895,050~ $0~